Operator Ladies and gentlemen, with this, the conference has now concluded and you may disconnect your telephone. Thank you for joining and have a pleasant day. Goodbye. So, specifically what people say no to, I think people, the data should tell that. We are in the process because value proposition is attractive in a world of IRA, cost constraint, in a world of providing access to biologics. This is an important proposition. And in short, we have maybe some partners who are not attractive to that, but whoe ...

Evotec SE (OTCPK:EVOTF) Q3 2022 Results Conference Call November 9, 2022 8:00 AM ET Company Participants Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Craig Johnstone - Chief Operating Officer Cord Dohrmann - Chief Scientific Officer Matthias Evers - Chief Business Officer Conference Call Participants Zoe Karamanoli - RBC Capital Markets Christian Ehmann - Warburg Research James Quigley - Morgan Stanley Derik de Bruin - Bank of America Peter Welford - Jefferies Joe Hedde ...

Evotec SE (OTCPK:EVOTF) Q2 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants | --- | |------------------------------------------------| | | | Dr. Werner Lanthaler - Chief Executive Officer | | Enno Spillner - Chief Financial Officer | | Cord Dohrmann - Chief Scientific Officer | | Craig Johnstone - Chief Operating Officer | | Matthias Evers - Chief Business Officer | | Conference Call Participants | | | | Zoe Karamanoli - RBC Capital Markets | | James Quigley - Morgan Stanley | | ...

| --- | --- | |---------------------------------------------------|-------| | | | | Accelerating precision medicine | | | Evotec SE, H1 2022 Interim Report, 11 August 2022 | | Cautionary statement regarding forward-looking statements Information set forth in this presentation contains forward-looking statements, which involve a number of risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as "anticipate", "b ...

Exhibit 99.1 volker.braun@evotec.com, T. +49.(0)40.560 81-775, M. +49.(0)151.1940 5058, www.evotec.com #RESEARCHNEVERSTOPS HALF-YEAR REPORT 2022 Half-year Interim Report PUBLICATION DATE: 11 AUGUST 2022 -- For further information, please contact: Volker Braun, SVP Head of Global Investor Relations & ESG, HALF-YEAR REPORT 2022 I. MANAGEMENT REPORT 4 NEW AND EXTENDED ALLIANCES UNDERLINE SUCCESS OF GROWTH STRATEGY 4 ACQUISITION EXPANDS CAPABILITIES AND EXPERTISE IN CELL THERAPY 4 GUIDANCE FOR FULL-YEAR 2022 RE ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ Form 20-F ___________________________ (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition p ...

Evotec SE (NASDAQ:EVO) Q4 2021 Earnings Conference Call April 12, 2022 8:00 AM ET Company Participants Werner Lanthaler - Chairman and Chief Executive Officer Cord Dohrmann - Chief Scientific Officer Craig Johnstone - Chief Operating Officer Enno Spillner - Chief Financial Officer Conference Call Participants James Quigley - Morgan Stanley Joseph Hedden - Rx Securities Falko Friedrichs - Deutsche Bank Igor Kim - Berenberg Michael Ryskin - Bank of America Zoe Karamanoli - RBC Capital Markets Operator Dear la ...

Evotec SE (OTCPK:EVOTF) Q2 2021 Results Earnings Conference Call August 11, 2021 8:00 AM ET Company Participants Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright & Co. Joseph Hedden - Rx Securities Falko Friedrichs - Deutsche Bank Christian Ehmann - Warburg Research Victoria English - MedNous Operator Dear, ladies and gentlemen, welcome to the conference call of Evotec SE. At our customer's request, this c ...

U MECCABCHNEVERJIUTO Driving growth & Getting ready for launch 【】【】【【】【 Evotec SE, H1 2021 Interim Report, 11 August 2021 Cautionary statement regarding forward-looking statements Information set forth in this presentation contains forward-looking statements, which involve a number of risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as "anticipate", "believe", "could", "estimate", "expect", "goal", "inten ...

Evotec SE (OTCPK:EVOTF) Q1 2021 Earnings Conference Call May 11, 2021 8:00 AM ET Company Participants Werner Lanthaler - CEO Enno Spillner - CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright & Co. Christian Ehmann - Warburg Research Falko Friedrichs - Deutsche Bank Charles Weston - RBC Capital Markets Victoria English - MedNous Joseph Hedden - Rx Securities Limited Alex Cogut - Kempen & Co. Naresh Chouhan - Intrinsic Health Advisors Operator Dear ladies and gentlemen, welcome to the c ...